In pathologic T stages, T3 and T4 ccRCC patients expressed higher CKAP2L levels (Figure 3B), especially in the tumor T4 stage, where CKAP2L was significantly higher than in the other three T stages (Figure 3B). Here, CKAP2L is linked to nonpapillary renal cell carcinoma.